Skip to the page

Data / Form D filings / Primary Bioscience, Inc.

Primary Bioscience, Inc.: Form D filings

Primary Bioscience, Inc., a technology company in Seattle, WA, filed 3 Form D notices with the SEC between 2025 and 2026. The latest, on June 23, 2026, reports $1.3 million sold of a $1.8 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
7335 14TH AVE NW, Seattle, WA, 98117
Phone
(414) 293-2303
Industry
Other Technology
Entity type
Corporation
Incorporated in
Washington
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2012695

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 23, 2026Amendment$1,800,000$1,300,000$500,0003Oct 2, 2025sec.gov
Oct 24, 2025Amendment$1,300,000$1,100,000$200,0002Oct 2, 2025sec.gov
Oct 7, 2025New notice$300,000$100,000$200,0001Oct 2, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Stacy AndersonExecutive Officer, Director, Promoter

Other technology companies in Washington that filed recently

Every Form D from the week of Jun 22, 2026 · All recent filings in Washington · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Primary Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.